会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • MITOCHONDRIALLY TARGETED COMPOUNDS
    • MITOCHENDRIALLY目标化合物
    • WO1999026582A2
    • 1999-06-03
    • PCT/NZ1998000172
    • 1998-11-25
    • UNIVERSITY OF OTAGOMURPHY, Michael, PatrickSMITH, Robin, A., J.
    • UNIVERSITY OF OTAGO
    • A61K00/00
    • C07F9/65522A61K47/54A61K47/543C07F9/54C07F9/5722
    • The invention provides mitochondrially targeted compounds. A compound of the invention comprises a lipophili cation covalently coupled to a therapeutically or prophylactically useful compound. In preferred embodiments the therapeutically or prophylactically useful compound is an antioxidant moiety. In particularly preferred embodiments, the lipophilic cation is the triphenylphosphonium cation, and the compound is of the formula P(Ph3) XR.Z where X is a linking group, Z is an anion and R is an antioxidant moiety. Also provided are pharmaceutical compositions containing the mitochondrially targeted compounds, and methods of therapy or prophylaxis of patients who would benefit from reduced oxidative stress, which comprise the step of administering the antioxidant compounds of the invention.
    • 本发明提供线粒体靶向化合物。 本发明的化合物包含与治疗或预防有用的化合物共价偶联的亲脂体。 在优选的实施方案中,治疗或预防有用的化合物是抗氧化剂部分。 在特别优选的实施方案中,亲脂性阳离子是三苯基鏻阳离子,化合物具有式P(Ph 3)XR.Z-,其中X是连接基团,Z是阴离子,R是抗氧化剂部分 。 还提供了含有线粒体靶向化合物的药物组合物,以及治疗或预防受益于减少的氧化应激的患者的方法,其包括给予本发明的抗氧化剂化合物的步骤。